Sunday, May 3, 2015


  • More Top Stories
  • Latest News
As 8-year-old Molly Vergin was preparing to try to break the world record for the most high-fives in one minute, no one was concerned about the magnitude of the challenge: to complete 261 hand slaps in 60 seconds.
A blood test known as a "liquid biopsy" could help doctors track a shifty type of lung cancer without the need for invasive procedures, an international team of researchers says.
John Seffrin, 70, chief executive officer of the American Cancer Society, will retire next Friday after 40 years with the venerable nonprofit cancer-fighting organization, including 23 at the helm.
Keytruda, Yervoy and other medications harness immune cells to target cancers, experts say
Keytruda is already approved to treat melanoma
Researchers who study hereditary breast and ovarian cancer call it "the Angelina Jolie Effect." They reported a sustained global surge in requests for BRCA genetic testing after the actress wrote about her preventive mastectomy two years ago. Last month, she gave another boost to awareness when she wrote about her recent surgery to remove her ovaries.
Susan Funck got the horrible news on her 47th birthday - Aug. 27, 2012. Her 13-year-old daughter, Hannah Duffy, had a brain tumor. A biopsy later confirmed that the tumor was malignant. It would be fatal.
Tim Lynch has a theory about why he beat the brutal brain cancer glioblastoma. Even with intensive treatment, the average survival is about 15 months. As the tumor grows, it destroys the very abilities that define people as human - thinking, feeling, communicating.
Charlotte Beard finally found a hair stylist who knows what it’s like to lose your hair.
Compounds in breath may signal chances of developing deadly disease, researchers say
No one would chide a bald chemo patient for making bad decisions about her hair. But a stranger told one of Beth Eaby-Sandy's cancer patients - a woman whose treatment had made her skin turn bright red - that she "really should wear sunscreen."
Unlike the imaginary monsters of our childhoods, the ones lurking under the beds, in the closets or outside the windows on moonlit nights, the monster haunting Deborah Romero is real.
When researchers talk about the new, mostly experimental form of cancer treatment known as immunotherapy, they often use glowing terms like revolutionary and transformative.
Multiple gene mutations identified that could be targets for treatment
The breakthrough cancer immunotherapy being developed by the University of Pennsylvania and Novartis Pharmaceuticals can now move ahead without the cloud of a patent lawsuit.
Small reduction seen with cholesterol-lowering drugs, but study couldn't prove cause-and-effect link
No differences in survival or recurrence in women who chose to keep nipple, researcher says
Intense physical activity throughout life was linked to a 30 percent reduction in risk, study suggests
Study finds most breast cancer patients will need two or more procedures to complete process
Shortage of vitamin D may be to blame
Two experimental medications target mutation that fuels treatment resistance
Strongest benefit seen in most common types of tumors, researchers say
Study found more polyps, other markers of colon tumor risk in those eating 'Western' high-fat, low-fiber fare
Study suggests chemotherapy, radiation can damage the heart for decades to come
Usage doesn't always comply with national guidelines
Better pre-surgical chemotherapy means more of the breast can safely be saved, researchers say
Experimental devices might reduce risk of side effects, lower costs, researchers say
Researchers have begun early human trials, say findings could lead to blueprint for tailored treatments
Upcoming Event